CNBX Pharmaceuticals Inc. (CNBX) Other Non-Current Liabilities (2018 - 2020)
CNBX Pharmaceuticals' (CNBX) quarterly Other Non-Current Liabilities came in at $2.8 million in Q2 2020, little changed YoY from $2.8 million in Q2 2019, and little changed on a QoQ basis from $2.8 million in Q1 2020.
CNBX Pharmaceuticals Inc. (CNBX) Other Non-Current Liabilities (2018 - 2020) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 3 years of Other Non-Current Liabilities data on file, last reported at $2.8 million in Q2 2020.
- Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $2.8 million in Q2 2020, while the trailing twelve-month figure through May 2020 was $2.8 million (changed 0.0% YoY) and the FY2019 annual result came in at $2.8 million, up 3003.35% from the prior year.
- Other Non-Current Liabilities steadied at $2.8 million in Q2 2020, from $2.8 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $2.8 million in Q4 2018 to a low of $89722.0 in Q3 2018.
- A 3-year average of $2.4 million and a median of $2.8 million in 2018 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 3003.35% in 2019, down 0.0% in 2019.
- Tracing CNBX's Other Non-Current Liabilities over 3 years: stood at $2.8 million in 2018, then dropped by 0.0% to $2.8 million in 2019, then advanced by 0.0% to $2.8 million in 2020.
- The last three Other Non-Current Liabilities figures came in at $2.8 million (Q2 2020), $2.8 million (Q1 2020), and $2.8 million (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2020 | 2.78 Mn |
| Feb 29, 2020 | 2.78 Mn |
| Nov 30, 2019 | 2.78 Mn |
| Aug 31, 2019 | 2.78 Mn |
| May 31, 2019 | 2.78 Mn |
| Feb 28, 2019 | 2.78 Mn |
| Nov 30, 2018 | 2.78 Mn |
| Aug 31, 2018 | 89,722.00 |